Your Exit Timeline Starts Now if You Want Maximum Value

Two practices on the same suburban strip, both collecting about $1.6 million, both with four operatories and a hygienist who's been there twelve years. One sold for $800,000. The other sold for $1.9 million three years later, and the difference had almost nothing to do with the broker, the market, or the negotiation.

Here's the claim an informed owner can argue with: your sale price is effectively locked in about 36 months before closing, and the work that sets it will cost you roughly $47,000 a year in personal income to perform. Most owners believe the opposite. They believe the price is discovered at the end, through a competitive process, by a good advisor who knows which DSOs are buying in their state. That belief is worth about a million dollars, and not in your favor.

Where the 5x to 8x Range Actually Comes From

Current pricing for dental practices runs 5 to 8 times EBITDA for a single location or DSO add-on, 9 to 11 times for regional DSO and private equity platforms, and 10 to 12 times or more for large PE-backed platforms. Owners read that range and assume it's a market condition, something that happens to them based on timing and geography.

It isn't. Within the single-location band, the spread between 5x and 8x is a risk score, and the risk being scored is one specific question: does this cash flow survive the owner walking out the door? At 5x, the buyer is saying the practice is a job with equipment attached. At 8x, they're saying it's a business that happens to have a dentist in it.

The two numbers you're sold on move in the same direction, which is why the gap compounds. An owner-dependent practice has a smaller EBITDA base, because one set of hands caps production while fixed overhead doesn't care. Then that smaller base gets the smaller multiple. You lose on both sides of the equation at once.

$1.1 Million Sits Between 5x and 7x on the Same Building

Run it with real numbers. Take a practice collecting $1.6 million today. The owner personally produces $1.2 million of that. One part-time associate produces the remaining $400,000. Non-doctor operating expenses (staff, rent, supplies, lab, everything but dentist compensation) run 58 percent, or $928,000.

A buyer normalizes the owner's production at market replacement compensation, call it 32 percent, so the owner's $1.2 million costs $384,000 to replace, and the associate's $400,000 of production costs $128,000. Adjusted EBITDA is $1,600,000 minus $928,000 minus $128,000 minus $384,000, which lands at $160,000.

That's a 10 percent EBITDA margin on a practice the owner considers successful. At the bottom of the single-location band, 5x, this practice is worth $800,000.

Now run the same building three years later, after the owner deliberately hires a second associate and moves themselves from four clinical days to two. Total collections reach $2.1 million, because the chairs run more hours and hygiene finally has doctor coverage for same-day treatment. Non-doctor expenses scale to 55 percent of the larger number, or $1,155,000, since rent and front-desk salaries didn't grow proportionally.

The owner now produces $700,000; the two associates produce $1,400,000. Associate compensation runs $448,000, and the owner's replacement cost falls to $224,000. Adjusted EBITDA is $2,100,000 minus $1,155,000 minus $448,000 minus $224,000, or $273,000.

That's a 13 percent margin on a practice where the selling doctor is responsible for one-third of production instead of three-quarters. Buyers price that at 7x, not 5x, because the transition risk is visibly lower. Seven times $273,000 is $1,911,000.

The gap between the two outcomes is $1,111,000 on the same street, same patients, same equipment.

Now the part owners flinch at. In year zero, the owner's total annual take is replacement comp plus EBITDA: $384,000 plus $160,000, or $544,000.

In year three, it's $224,000 plus $273,000, or $497,000.

So the owner gives up about $47,000 a year, roughly $141,000 across the three-year build, to add $1.1 million to the exit.

That's about $7.90 of sale price for every $1 of income voluntarily surrendered.

Our view: that's the single best-returning investment available to a 58-year-old practice owner, and almost none of them make it, because the cost shows up in this month's draw and the payoff shows up at a closing table three years out. We'd take the pay cut. We'd take it the same quarter we decided to sell, and we'd take it before we ever called a broker.

One honest caveat on the mechanics. Swapping your production to an associate is close to EBITDA-neutral by itself, since the buyer normalizes your compensation either way. The value doesn't come from the handoff. It comes from what the handoff makes possible: capacity above one person's hands, and a multiple that reflects a practice which keeps producing when you stop.

What Most Owners Get Wrong: The Coast-Down Years

The specific mistake, made by the specific person, looks like this. A 62-year-old solo owner decides to slow down. They go from five clinical days to four, then to three. They stop taking new patients on Fridays. They quit the study club, let the recall system drift, defer the operatory renovation because "the buyer will want to do it their way anyway," and stop replacing the hygienist who left.

Every one of those decisions is individually reasonable and collectively catastrophic. Collections fall from $1.6 million to $1.3 million over four years. Fixed overhead doesn't fall with it, so EBITDA falls faster than collections do. And the buyer isn't valuing your best year. They're valuing trailing twelve months against a visible trend line, and a declining trend line pushes you to the bottom of the multiple range at the exact moment your base is smallest.

A practice that needs you is a job you can't sell. A practice that doesn't need you is an asset with a multiple. The coast-down converts the second into the first, one deferred decision at a time, and it is the most expensive habit in dentistry.

The Associate Who Was Going to Buy You Out Didn't Buy a Practice

The old plan was simple: hire a young dentist at 35, sell them a share at 38, hand over the keys at 42. That exit is closing.

Among dentists aged 30 to 34, ownership fell from more than half in 2005 to only one-third by 2021, and fewer than 1 in 10 dentists under 30 owned a practice in 2021. Meanwhile, DSO affiliation among all U.S. dentists rose from 8.8 percent in 2017 to 10.4 percent in 2019 to 13 percent in 2022, and 23 percent of dentists with under 10 years of experience were DSO-affiliated in 2022.

Read those two facts together and the conclusion is uncomfortable. Nearly a quarter of the cohort you'd have sold to has already signed with someone who isn't you, and the rest are carrying student debt into a market where a bank wants a personal guarantee on a $1.5 million note. Your buyer pool is concentrating toward institutional capital, and institutional capital does not buy goodwill, patient loyalty, or the fact that you've been in that building since 1998. It buys EBITDA, and it underwrites the risk that the EBITDA walks out with you.

That's not a complaint about DSOs. It's a pricing signal. The buyer who would have paid you a relationship premium is scarce. The buyer who remains pays a spreadsheet price. Build for the spreadsheet.

Drop the PPO in Year Three, Not Year One

Margin work belongs in the plan, but the timing matters more than the decision. Owners who want to improve EBITDA before a sale often reach for the biggest lever available: dropping their worst-paying plan. Right instinct, usually wrong clock.

Before you drop anything, run the Break-Even Retention Test: divide net collections per visit under the plan by net collections per visit out of network. That quotient is the share of those patients you must keep for collections to stay flat. If the plan pays you 62 cents on your out-of-network dollar, you need to retain 62 percent of that cohort to break even, and anything above that is pure margin.

Here's the exit-specific wrinkle. Even a successful plan exit produces a dip before it produces a lift: patients churn, schedules gap, collections wobble for two or three quarters before the improved per-visit economics show up in the annual number. If you run that play 14 months before closing, the buyer sees a declining trailing twelve months and prices the decline, not the recovery. Run it 30 months out and they see two clean years of improved margin. Same decision, six figures of difference in what it's worth.

Two or Three Years Is the Floor, Not the Plan

Henry Schein's transitions group recommends beginning transition planning at least two to three years before the intended retirement or sale date. We'd treat that as the minimum for a practice already in good shape, not the target for one that isn't. Recruiting an associate, keeping them, growing collections through them, and producing two clean years of financials on the far side of that hire takes longer than 24 months in most markets.

There's also a supply problem forming. The average dentist retirement age rose from 64.8 in 2001 to 67.9 in 2021, with average career span climbing from 37.9 years to 40.4. Dentists who delayed are now arriving at the exit door at the same time, and they are arriving with practices that were run for income rather than for sale. When a lot of similar assets hit the market together, the spread between the good ones and the average ones widens. Being at 7x when your neighbor is at 5x isn't luck at that point. It's the only thing that matters.

And if you're eyeing the 9x to 12x bands, be clear about what they cost. Those multiples attach to platforms, not to single locations, and reaching them usually means rolling equity into someone else's company and accepting their outcome as your own. That can be the right trade. It's a different decision from selling, and it should be priced as one.

Your Next Ninety Days

Pull a three-year trend on collections, non-doctor overhead as a percentage, and your personal production share, then calculate adjusted EBITDA the way a buyer will, normalizing your own compensation at 32 percent of what you produce. If your production share is above 60 percent, start recruiting an associate this quarter even if the schedule says you don't need one, because that hire takes nine months to find and eighteen to season. Run the Break-Even Retention Test on your two worst-paying plans now, while you still have runway to absorb the dip. And write down your target closing date, then subtract 36 months and mark that date, because that is when the price gets set.

If you want to see where your practice actually prices today, and what a two-point shift in overhead or a ten-point shift in your production share does to the number, run your own numbers through our valuation calculator and compare your adjusted EBITDA against the 5x to 8x band before anyone else does it for you.

What we're watching: whether the single-location band holds at 5x to 8x as the retirement bulge pushes more practices onto the market at once, or whether the bottom of that range slips while platform multiples hold. If add-on pricing compresses toward 4x for owner-dependent practices, the $47,000-a-year trade gets more attractive, not less. If a real private-buyer market returns among dentists in their thirties, we'd revisit the whole argument.